Tricuspid Regurgitation and Impact of Surgical Valve Intervention in the Single Ventricle Reconstruction Trial - Scorecard - MDSpire

Tricuspid Regurgitation and Impact of Surgical Valve Intervention in the Single Ventricle Reconstruction Trial

  • By

  • J. F. Cnota

  • S. M. Chowdhury

  • A. Floh

  • R. Gongwer

  • B. H. Goot

  • J. P. Jacobs

  • M. A. Jolley

  • S. Kirmani

  • D. J. LaPar

  • J. C. Levine

  • A. B. Lewis

  • R. H. Pignatelli

  • C. Pizarro

  • T. C. Slesnick

  • T. Thorsson

  • F. Trachtenberg

  • D. T. Truong

  • J. W. Newburger

  • P. C. Frommelt

  • February 18, 2026

  • 0 min

Share

Clinical Scorecard: The Role of Surgical Valve Intervention on Tricuspid Regurgitation in Patients Undergoing Single Ventricle Reconstruction Trial

At a Glance

CategoryDetail
ConditionTricuspid valve regurgitation in single right ventricle anomalies
Key MechanismsTethering of septal leaflet, cleft leaflets, annular dilation, leaflet prolapse
Target PopulationInfants with single right ventricle anomalies undergoing staged surgical palliation
Care SettingPediatric cardiac surgery and longitudinal echocardiographic follow-up

Key Highlights

  • Moderate or greater tricuspid regurgitation prior to Norwood procedure is associated with worse transplant-free survival at 6 years (HR 1.77).
  • The proportion of patients with > mild TR increases significantly post-Norwood and remains stable through 6 years.
  • Right ventricular size and function show modest association with TR severity only at the post-Norwood time point.

Guideline-Based Recommendations

Diagnosis

  • Use serial 2D/Doppler echocardiography at predefined time points to assess TR severity qualitatively by vena contracta size.
  • Categorize TR as none, mild, moderate, or severe; dichotomize as ≤ mild or > mild for clinical decision-making.

Management

  • Consider surgical tricuspid valve intervention during staged palliation, though effective long-term strategies remain elusive.
  • Monitor TR severity closely after Norwood procedure to identify patients at higher risk for adverse outcomes.

Monitoring & Follow-up

  • Perform echocardiograms at baseline, early post-Norwood, pre-stage II, 14 months, pre-Fontan, and post-Fontan (6 years).
  • Assess right ventricular size and function alongside TR severity to guide prognosis.

Risks

  • Presence of > mild TR is associated with increased risk of death or cardiac transplantation.
  • Surgical intervention timing and impact on long-term outcomes require careful consideration due to variable results.

Patient & Prescribing Data

Infants with single right ventricle anomalies undergoing Norwood procedure and staged palliation

TR severity prior to and following Norwood procedure is a prognostic marker; surgical intervention impact on survival is under investigation.

Clinical Best Practices

  • Perform comprehensive echocardiographic assessment of TR at standardized intervals during staged palliation.
  • Use TR severity as a dynamic marker to stratify risk and guide timing of potential surgical valve interventions.
  • Incorporate RV size and function measurements to contextualize TR severity and patient prognosis.
  • Exclude patients with conversion to biventricular physiology from TR outcome analyses to maintain cohort consistency.

References

Original Source(s)

Related Content